EDWARDS LIFESCIENCES REPORTS SECOND QUARTER RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Edwards Lifesciences (EW) Down on Earnings Miss as Hospital Staffing 'Remains Uncertain'
July 29, 2022 1:32 PM EDTEdwards Lifesciences (NYSE: EW) shares have fallen over 6% Friday on the back of its earnings release.
The company reported after the close Thursday, missing earnings and revenue expectations.
Edwards Lifesciences reported earnings of $0.63, $0.01 worse than the analyst estimate of $0.64 on revenue of $1.37 billion, missing the consensus estimate of $1.4 billion.
The company said it experienced persistent disruption within the healthcare... More
Edwards Lifesciences (EW) Misses Q2 EPS by 1c, Q3 Revenue Guidance Misses
July 28, 2022 4:18 PM EDTEdwards Lifesciences (NYSE: EW) reported Q2 EPS of $0.63, $0.01 worse than the analyst estimate of $0.64. Revenue for the quarter came in at $1.37 billion versus the consensus estimate of $1.4 billion.
GUIDANCE:
Edwards Lifesciences sees Q3 2022 EPS of $0.58-$0.66, versus the consensus of $0.65.... More
